Myogenic reprogramming of bone marrow derived cells in a W⁴¹Dmd(mdx) deficient mouse model.
Lack of expression of dystrophin leads to degeneration of muscle fibers and infiltration of connective and adipose tissue. Cell transplantation therapy has been proposed as a treatment for intractable muscle degenerative disorders. Several reports have demonstrated the ability of bone-marrow derived...
Guardado en:
Autores principales: | Stuart Walsh, Jens Nygren, Annica Pontén, Stefan Jovinge |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Public Library of Science (PLoS)
2011
|
Materias: | |
Acceso en línea: | https://doaj.org/article/acfdbed83045419f84768dd6f676bff6 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Author Correction: Humanizing the mdx mouse model of DMD: the long and the short of it
por: Nora Yucel, et al.
Publicado: (2020) -
Macrophages improve survival, proliferation and migration of engrafted myogenic precursor cells into MDX skeletal muscle.
por: Pierre-François Lesault, et al.
Publicado: (2012) -
PMO-based let-7c site blocking oligonucleotide (SBO) mediated utrophin upregulation in mdx mice, a therapeutic approach for Duchenne muscular dystrophy (DMD)
por: Kasturi Sengupta, et al.
Publicado: (2020) -
Increased neointimal thickening in dystrophin-deficient mdx mice.
por: Uwe Rauch, et al.
Publicado: (2012) -
Decrease in prosaposin in the Dystrophic mdx mouse brain.
por: Hui-Ling Gao, et al.
Publicado: (2013)